FDA approves first drug to specifically treat giant cell arteritis

By Newsroom America Feeds at 22 May 2017

The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type of vasculitis.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm559791.htm

Categories:
Tags:

[D] [Digg] [FB] [R] [SU] [Tweet] [G]

NEWSMAIL